Regulatory review: Taiwan's new laws for vitamin labelling, Australia drafting FMT regulations and more

By Tingmin Koe

- Last updated on GMT

This regulatory review looks at developments in Taiwan, Japan, Australia, and China. ©Getty Images
This regulatory review looks at developments in Taiwan, Japan, Australia, and China. ©Getty Images

Related tags regulations China Japan Taiwan Australia

See the regulatory developments happening in APAC in the past one month, including Taiwan FDA's new rules for vitamins labelling, Australia drafting regulations to govern the manufacturing process and uses of faecal microbiota transplant (FMT) products.
Taiwan nutritional labelling: FDA introduces new laws for vitamin and mineral supplements

Taiwan FDA has announced amendments​ to the way vitamins and minerals are labelled in the country, where the main revisions are the vertical format of nutrition labels, and units for nutrient values.

The changes apply to vitamin and mineral tablets and capsules which are used as nutritional supplements.

The regulation​ is established under the provisions of Item 3 of Article 22 of the Food Safety and Sanitation Management Law (Regulations on Nutrition Labeling for Prepackaged Vitamin and Mineral Tablets and Capsules).

Genome-edited food products to go on sale in Japan, despite no labelling and safety provisions

Food products produced using genome editing technology could go on sale in Japan​ by the end of the year despite no specific labelling rules being in place.

The Consumer Affairs Agency (CAA) announced that foods made using the genome editing technology do not require safety inspections, unlike genetically modified foods which must go through toxicity and carcinogenicity tests.

Declaration of the technology used is also not required on the product label.

FMT rules for 2020: Australian TGA to draft standards for faecal microbiota transplant products

Australia’s Therapeutic Goods Administration (TGA) is drafting a new regulation​ which will govern the manufacturing process and uses of faecal microbiota transplant (FMT) products.

The regulator is planning to introduce the finalised version of “Therapeutic Goods Order (TGO): Standards for Faecal Microbiota Transplant Products”​next year, accompanied with a transition period of 12 months. 

FMT is the process of transplanting gut microflora in human stool or products processed from human stool from a healthy human donor into the bowel of a recipient with a medical condition.

Name game: China’s SAMR releases new manual for naming of health foods

China’s State Administration for Market Regulation (SAMR) has introduced the 2019 version of its ‘Health Foods Naming Directory’​ to standardise the naming of products.

The document, written based on the Food Safety Law and Health Foods Registration and Filing regulations, was published earlier this month. 

The new document​ was produced following a one-month public consultation in October last year.

Aussie sports nutrition regulations: Industry urges regulator to assess impact and stem illegal imports

Australia’s trade body Complementary Medicines Australia (CMA) has urged​ national regulator Therapeutic Goods Administration (TGA) to conduct a proper impact assessment amid the latter’s proposal to classify certain sports nutrition as therapeutic goods.

The TGA recently released a public consultation, proposing to classify​ non-food appropriate sports nutrition as therapeutic goods, potentially making them subject to same regulations as complementary medicines (supplements).

The move is to strengthen regulations on sports nutrition products as the country confronts a number of high-profile deaths arising from the consumption of non-compliant products.

Related news

Show more

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Related suppliers

Follow us

Products

View more

Webinars

Nutra Champions Podcast

Nutra Champions Podcast